Status:
UNKNOWN
The Asian Pacific TAVR Multicenter Registry
Lead Sponsor:
Michael Kang-Yin Lee, MD
Collaborating Sponsors:
Asan Medical Center
Cardiovascular Clinical Research
Conditions:
Aortic Valve Stenosis
Eligibility:
All Genders
Brief Summary
The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve Replacement (TAVR) in the Asian Pacific population
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.
- The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.
Exclusion
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT02195102
Start Date
December 1 2014
End Date
December 1 2021
Last Update
November 18 2014
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Elizabeth Hospital
Hong Kong, China
2
Nanjing 1st Hospital
Nanjing, China
3
Shonan Kamakura General Hospital
Kamakura, Japan
4
Institut Jantung Negara
Kuala Lumpur, Malaysia